NR4A1 and neoplasm: Prognostic factors indicative of unfavorable outcomes, but also predictive of risk reduction in patients undergoing chemotherapy, are tumor size, loco-regional lymph node involvement, tumor histotype, hormone receptor expression, HER2/neu overexpression, Mib-1/Ki-67 proliferation index, tumor grade, perivascular or perineural invasion, and the young age of the patient [5, 32, 34, 52–54].